Welcome to Artificially Real, the only life sciences blog dedicated to AI solutions expanding Real World Data research.
Understand the biggest trends in AI impacting the Life Sciences industry. Understand the business values companies are recognizing through the use of LLMs and RWD.
Learn about changes companies have to make to achieve their business goals. Hear about the latest regulatory changes impacting your business operations.
Learn about industry best practices for designing, implementing, operating, and managing AI programs effectively.
Hear about critical regulatory, compliance, and privacy requirements as they change.
Learn how colleagues and peers how tackled similar challenges.
Learn about the innovative AI initiatives being undertaken by fellow Life Sciences firms.
Understand the business goals, processes, changes, and advancements undertaken to realize measurable value from the programs.
See the impacts realized by these inititives.
Read reviews of vendors that offer valuable components needed for effective RWD, AI, and analytics programs.
Learn about the capabilities, functionality, and focus of different vendors. Understand their developments and progress. We continually update our vendor listings to reflect the latest details.
Tags
How AI is Expanding RWD for Clinical Trial Recruitment
Clinical Trials are the backbone of pharmaceutical innovation, driving the engine of development of new safe and efficacious drugs.
Artificial Intelligence (AI) is emerging as a game-changer in patient recruitment. Given the ability to process Real World Data (RWD) and other datasets rapidly, efficiently, and at scale, AI can deliver faster and more extensive data-driven insights. AI can streamline patient recruitment, identifying eligible patients, prioritizing those most suitable for specific trials, and even enhance recruitment efforts, ultimately making the process more efficient and cost-effective.
